Repaglinide (RPG) is an oral medication belonging to the meglitinide class, primarily used to treat Type 2 diabetes mellitus. It functions by stimulating the pancreas to release insulin, but uniquely, it acts rapidly and for a short duration. This mechanism mimics the body's natural insulin surge, effectively controlling the post-meal spike in blood glucose levels. Unlike some other diabetes drugs, Repaglinide has a low risk of causing hypoglycemia if meals are skipped. It is typically taken right before main meals to manage blood sugar flexibly, offering a valuable option for patients with irregular eating schedules.

Product Advantages: 

Easy Visual Interpretation

Convenient Procedure

High Accuracy

Fast Results in 5 Minutes